News from viiv healthcare A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 25, 2014, 19:32 ET

ViiV Healthcare recibe aprobación de la FDA para Triumeq® (abacavir, dolutegravir y lamivudine), una nueva régimen de tableta única para el tratamiento de la infección por VIH-1

El material multimedia relacionado con el aviso a continuación ya está disponible. El material incluye: material complementario en video,...

Aug 25, 2014, 09:00 ET

Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection

 On August 22, ViiV Healthcare announced that the US Food and Drug Administration (FDA) approved Triumeq® (abacavir 600mg, dolutegravir...

Aug 22, 2014, 15:46 ET

ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection

ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq® (abacavir 600mg, dolutegravir 50mg and...

Jun 14, 2014, 13:59 ET

ViiV Healthcare annonce un nouveau projet de collaboration avec Janssen en vue de mettre au point un comprimé unique destiné au traitement d'entretien des patients contaminés par le VIH-1

- Cet accord représente le premier projet de collaboration externe de ViiV Healthcare dans le cadre de la mise au point d'un comprimé...

Jun 14, 2014, 13:53 ET

ViiV Healthcare meldet neue Kooperation mit Janssen zwecks Untersuchung eines Einzeltablettenpräparats für die Erhaltungstherapie bei HIV-1

- Vereinbarung ist ViiV Healthcares erste externe Kooperation zur Entwicklung einer Einzeltablette mit zwei kombinierten Wirkstoffen: Dolutegravir...

Jun 13, 2014, 18:06 ET

ViiV Healthcare y Janssen investigarán el régimen de tableta única para el tratamiento de mantenimiento del VIH-1

- El acuerdo es la primera colaboración externa de ViiV Healthcare para el desarrollo de una tableta de dos fármacos combinados:...

Jun 12, 2014, 06:17 ET

ViiV Healthcare announces new collaboration with Janssen to investigate single-tablet regimen for maintenance treatment of HIV-1

ViiV Healthcare today announced that they have entered into an agreement with Janssen R&D Ireland Ltd (Janssen) for the development and...

Jun 10, 2014, 07:00 ET

Una encuesta nacional identifica posibles obstáculos para el tratamiento contra el VIH en los EE. UU.

 ViiV Healthcare anunció hoy nuevos datos de una encuesta que proporciona importantes detalles que pueden ayudar a explicar el motivo por...

Jun 10, 2014, 07:00 ET
National Survey Identifies Potential Barriers to HIV Treatment Use in U.S. (PRNewsFoto/ViiV Healthcare)

National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.

 ViiV Healthcare today announced new survey data that provide important insights that may help explain why HIV treatment rates remain low in...

Apr 01, 2014, 14:30 ET

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name...

Mar 19, 2014, 09:45 ET

ViiV Healthcare Announces Next Round of the Positive Action Southern Initiative to Support Linkages to HIV/AIDS Care and Treatment Adherence

 ViiV Healthcare today issued a new request for letters of interest (LOIs) for the sixth round of its Positive Action Southern Initiative...

Jan 21, 2014, 06:52 ET

ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe

 ViiV Healthcare today announced that the European Commission has approved Tivicay™ (dolutegravir), an integrase inhibitor, for use...

Nov 22, 2013, 09:00 ET

Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV

 ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Oct 22, 2013, 12:53 ET

ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV

ViiV Healthcare today announced the submission of a regulatory application in the United States for its investigational single-tablet regimen (STR)...

Sep 12, 2013, 18:22 ET

ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1

 ViiV Healthcare today announced initial results from the Phase IIIb/IV FLAMINGO (ING114915) study. This open-label study, for the first time,...

Sep 04, 2013, 09:00 ET

ViiV Healthcare Expands HIV/AIDS Community Support in Hard-Hit Southern U.S.

 ViiV Healthcare announced today the first Positive Action Southern Initiative (PASI) grant awardees in Texas and Virginia and seven grant...

Aug 14, 2013, 19:16 ET

ViiV Healthcare anuncia la aprobación de Tivicay® (dolutegravir) en EE. UU. para el tratamiento del VIH-1

ViiV Healthcare tiene el gusto de anunciar hoy que la Administración de Drogas y Alimentos (Food and Drug Administration, FDA) de los...

Aug 12, 2013, 22:54 ET

UPDATE: Multimedia Assets Now Available: ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1

ViiV Healthcare is pleased to announce today that the U.S. Food and Drug Administration (FDA) has approved Tivicay® (dolutegravir) 50-mg...

Aug 12, 2013, 20:48 ET

ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1

ViiV Healthcare is pleased to announce today that the U.S. Food and Drug Administration (FDA) has approved Tivicay® (dolutegravir) 50-mg...

Nov 08, 2012, 03:30 ET

ViiV Healthcare commits nearly £4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children

ViiV Healthcare announced today that it has awarded nearly £4 million to 99 projects in 26 countries through its Positive Action for Children...